The chemical substance known as [(1H-Benzoimidazol-2-ylmethyl)-methyl-amino]-acetic acid dihydrochloride, with the CAS number 1158326-42-1, is a synthetic compound that features a benzoimidazole moiety, which is known for its biological activity and potential pharmacological applications. This compound is characterized by the presence of a benzoimidazole ring, a methylamino group, and an acetic acid functional group, which contribute to its overall chemical properties. As a dihydrochloride salt, it is typically more soluble in water compared to its free base form, enhancing its bioavailability for potential therapeutic uses. The presence of the dihydrochloride indicates that the compound can form stable ionic interactions, which may influence its behavior in biological systems. Its structure suggests potential applications in medicinal chemistry, particularly in the development of drugs targeting various biological pathways. However, specific details regarding its pharmacokinetics, toxicity, and therapeutic efficacy would require further investigation and empirical studies.

[(1H-Benzoimidazol-2-ylmethyl)-methyl-amino]-acetic acid dihydrochloride

1158326-42-1: The chemical substance known as [(1H-Benzoimidazol-2-ylmethyl)-methyl-amino]-acetic acid dihydrochloride, with the CAS number 1158326-42-1, is a synthetic compound that features a benzoimidazole moiety, which is known for its biological activity and potential pharmacological applications. This compound is characterized by the presence of a benzoimidazole ring, a methylamino group, and an acetic acid functional group, which contribute to its overall chemical properties. As a dihydrochloride salt, it is typically more soluble in water compared to its free base form, enhancing its bioavailability for potential therapeutic uses. The presence of the dihydrochloride indicates that the compound can form stable ionic interactions, which may influence its behavior in biological systems. Its structure suggests potential applications in medicinal chemistry, particularly in the development of drugs targeting various biological pathways. However, specific details regarding its pharmacokinetics, toxicity, and therapeutic efficacy would require further investigation and empirical studies.

CAS 1158326-42-1

[(1H-Benzoimidazol-2-ylmethyl)-methyl-amino]-acetic acid dihydrochloride